Literature DB >> 24197987

Vision specific quality of life in children with optic pathway gliomas.

Robert A Avery1, Kristina K Hardy.   

Abstract

Children with optic pathway gliomas (OPGs) frequently experience vision loss from their tumors. Most pediatric OPG research has focused on radiographic and visual outcomes, yet the impact of vision loss on quality of life (QOL) in children with OPGs has not been studied. The present study prospectively recruited children ≤ 10 years of age with sporadic or neurofibromatosis type 1 (NF1)-related OPGs. Vision specific QOL was assessed by parent proxy using the Children's Visual Function Questionnaire (CVFQ), and scores were analyzed according to magnitude of visual acuity (VA) loss and presence of visual field (VF) loss. Thirty-six subjects completed the study (53 % female) with median age of 4.6 years. Children with mild, moderate and severe vision loss have lower CVFQ subscale scores, indicating a lower vision specific QOL, compared to those with normal vision. Lower Competence scores were noted in participants with more profound vision loss (p < 0.05), reflecting a decreased ability to complete activities of daily living (e.g., feeding, grooming). Children with two visually impaired eyes were rated as having greater difficulty with social interactions and pleasurable activities (Personality subscale, p = 0.039) compared to those with only one impaired eye. In summary, our findings demonstrate that children with vision loss secondary to their OPG have a decreased vision specific QOL compared to those with normal vision. Measuring vision specific QOL may be considered a meaningful secondary outcome measure for pediatric OPG clinical trials.

Entities:  

Mesh:

Year:  2013        PMID: 24197987      PMCID: PMC3947291          DOI: 10.1007/s11060-013-1300-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

1.  Vision-related quality of life in patients with pituitary adenoma.

Authors:  Yoshifumi Okamoto; Fumiki Okamoto; Takahiro Hiraoka; Shozo Yamada; Tetsuro Oshika
Journal:  Am J Ophthalmol       Date:  2008-06-06       Impact factor: 5.258

2.  Vision-related quality of life and visual function after retinal detachment surgery.

Authors:  Fumiki Okamoto; Yoshifumi Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Am J Ophthalmol       Date:  2008-04-09       Impact factor: 5.258

3.  Visual function in working-age adults: early life influences and associations with health and social outcomes.

Authors:  Jugnoo S Rahi; Phillippa M Cumberland; Catherine S Peckham
Journal:  Ophthalmology       Date:  2009-06-27       Impact factor: 12.079

4.  The PedsQL Brain Tumor Module: initial reliability and validity.

Authors:  Stephanie N Palmer; Kathleen A Meeske; Ernest R Katz; Tasha M Burwinkle; James W Varni
Journal:  Pediatr Blood Cancer       Date:  2007-09       Impact factor: 3.167

Review 5.  Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Authors:  Robert Listernick; Rosalie E Ferner; Grant T Liu; David H Gutmann
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

6.  The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module.

Authors:  James W Varni; Tasha M Burwinkle; Ernest R Katz; Kathy Meeske; Paige Dickinson
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

Review 7.  Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research.

Authors:  Robert A Avery; Rosalie E Ferner; Robert Listernick; Michael J Fisher; David H Gutmann; Grant T Liu
Journal:  J Neurooncol       Date:  2012-07-28       Impact factor: 4.130

8.  Visual impairment and vision-related quality of life in working-age adults: findings in the 1958 British birth cohort.

Authors:  Jugnoo S Rahi; Phillippa M Cumberland; Catherine S Peckham
Journal:  Ophthalmology       Date:  2008-12-16       Impact factor: 12.079

9.  Validity and reliability of the Children's Visual Function Questionnaire (CVFQ).

Authors:  Eileen E Birch; Christina S Cheng; Joost Felius
Journal:  J AAPOS       Date:  2007-05-23       Impact factor: 1.220

10.  How young can children reliably and validly self-report their health-related quality of life?: an analysis of 8,591 children across age subgroups with the PedsQL 4.0 Generic Core Scales.

Authors:  James W Varni; Christine A Limbers; Tasha M Burwinkle
Journal:  Health Qual Life Outcomes       Date:  2007-01-03       Impact factor: 3.186

View more
  13 in total

Review 1.  Visual function in children with primary brain tumors.

Authors:  Jason H Peragallo
Journal:  Curr Opin Neurol       Date:  2019-02       Impact factor: 5.710

Review 2.  Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature.

Authors:  Ana-Maria Vranceanu; Vanessa L Merker; Elyse R Park; Scott R Plotkin
Journal:  J Neurooncol       Date:  2015-02-07       Impact factor: 4.130

Review 3.  Effects of Brain Tumors on Vision in Children.

Authors:  Jason H Peragallo
Journal:  Int Ophthalmol Clin       Date:  2018

4.  Impact of vision loss among survivors of childhood central nervous system astroglial tumors.

Authors:  Peter M K de Blank; Michael J Fisher; Lu Lu; Wendy M Leisenring; Kirsten K Ness; Charles A Sklar; Marilyn Stovall; Chris Vukadinovich; Leslie L Robison; Gregory T Armstrong; Kevin R Krull
Journal:  Cancer       Date:  2016-01-11       Impact factor: 6.860

Review 5.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

6.  Ophthalmological Findings in Youths With a Newly Diagnosed Brain Tumor.

Authors:  Myrthe A Nuijts; Inge Stegeman; Tom van Seeters; Marloes D Borst; Carlien A M Bennebroek; Dennis R Buis; Nicole C Naus; Giorgio L Porro; Michelle B van Egmond-Ebbeling; Elisabeth S M Voskuil-Kerkhof; JanWillem R Pott; Niels E Franke; Evelien de Vos-Kerkhof; Eelco W Hoving; Antoinette Y N Schouten-van Meeteren; Saskia M Imhof
Journal:  JAMA Ophthalmol       Date:  2022-10-01       Impact factor: 8.253

7.  Treatment of neurofibromatosis type 1.

Authors:  Caterina Sabatini; Donatella Milani; Francesca Menni; Gianluca Tadini; Susanna Esposito
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

8.  Longitudinal Change of Circumpapillary Retinal Nerve Fiber Layer Thickness in Children With Optic Pathway Gliomas.

Authors:  Robert A Avery; Avital Cnaan; Joel S Schuman; Carmelina Trimboli-Heidler; Chieh-Li Chen; Roger J Packer; Hiroshi Ishikawa
Journal:  Am J Ophthalmol       Date:  2015-07-29       Impact factor: 5.258

9.  Visual impairment in children with a brain tumor: a prospective nationwide multicenter study using standard visual testing and optical coherence tomography (CCISS study).

Authors:  M A Nuijts; M H Degeling; I Stegeman; A Y N Schouten-van Meeteren; S M Imhof
Journal:  BMC Ophthalmol       Date:  2019-11-09       Impact factor: 2.209

10.  A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1.

Authors:  Alice Heaney; Jeanette Wilburn; Shannon Langmead; Jaishri Blakeley; Susan Huson; Carly Jim; Stephen P McKenna
Journal:  SAGE Open Med       Date:  2019-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.